BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28276950)

  • 1. Evaluation of the effect of Spiritual care on patients with generalized anxiety and depression: a randomized controlled study.
    Sankhe A; Dalal K; Save D; Sarve P
    Psychol Health Med; 2017 Dec; 22(10):1186-1191. PubMed ID: 28276950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Spiritist Passe (Spiritual Healing) on the Psychophysiological Parameters in Hospitalized Patients.
    Carneiro ÉM; Moraes GV; Terra GA
    Adv Mind Body Med; 2016 Summer; 30(3):4-10. PubMed ID: 27874837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic, three-arm randomised controlled trial of spiritual healing for asthma in primary care.
    Cleland JA; Price DB; Lee AJ; Gerard S; Sharma A
    Br J Gen Pract; 2006 Jun; 56(527):444-9. PubMed ID: 16762126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scores of Hamilton depression, anxiety, and panic agoraphobia rating scales in patients with acute coronary syndrome.
    Vural M; Acer M; Akbaş B
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):43-7. PubMed ID: 18258533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
    Bradley P; Shiekh M; Mehra V; Vrbicky K; Layle S; Olson MC; Maciel A; Cullors A; Garces JA; Lukowiak AA
    J Psychiatr Res; 2018 Jan; 96():100-107. PubMed ID: 28992526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of spiritual care using spiritual pain assessment sheet for advanced cancer patients: A pilot non-randomized controlled trial.
    Ichihara K; Ouchi S; Okayama S; Kinoshita F; Miyashita M; Morita T; Tamura K
    Palliat Support Care; 2019 Feb; 17(1):46-53. PubMed ID: 30683167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
    Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF
    J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial.
    Park DM; Kim SH; Park YC; Kang WC; Lee SR; Jung IC
    J Ethnopharmacol; 2014 Dec; 158 Pt A():11-7. PubMed ID: 25456420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder.
    Kim YW; Lee SH; Choi TK; Suh SY; Kim B; Kim CM; Cho SJ; Kim MJ; Yook K; Ryu M; Song SK; Yook KH
    Depress Anxiety; 2009; 26(7):601-6. PubMed ID: 19242985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial.
    Leichsenring F; Salzer S; Jaeger U; Kächele H; Kreische R; Leweke F; Rüger U; Winkelbach C; Leibing E
    Am J Psychiatry; 2009 Aug; 166(8):875-81. PubMed ID: 19570931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fewer study participants needed to demonstrate superior antidepressant efficacy when using the Hamilton melancholia subscale (HAM-D₆) as outcome measure.
    Østergaard SD; Bech P; Miskowiak KW
    J Affect Disord; 2016 Jan; 190():842-845. PubMed ID: 25487682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of short-term and long-term psychotherapy in the treatment of depressive and anxiety disorders during a 5-year follow-up.
    Maljanen T; Knekt P; Lindfors O; Virtala E; Tillman P; Härkänen T;
    J Affect Disord; 2016 Jan; 190():254-263. PubMed ID: 26540079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.
    Patel NC; DelBello MP; Kowatch RA; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):327-35. PubMed ID: 16768640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.